Neuraxpharm’s Post

How old is TMS? 👉 rTMS was first established in 1985 by Dr Anthony Barker and colleagues in the UK. For the last 35+ years it has continued to be studied extensively by medical professionals and researchers all around the world. Today there is a wealth of medical research on TMS, with the advances and efficacies of this form of treatment continuing to grow. As time continues to progress, protocols are continuing to become more effective and convenient, and findings are beginning to emerge for a wider range of psychological and neurological conditions. 🧠 📒 At Modalis, our TMS techniques use a specific neuronavigation system developed by Brain Science Tools at Utrecht University (Netherlands). This system has been used extensively since 2004 in the research and clinical applications of TMS. 📒 In 2007, the TGA approved TMS in Australia for treating depression. The RANZCP also endorsed the treatment for depression in 2013, adding TMS to it’s Professional Practice Guidelines in 2018. 📒 In 2021, TMS was added to the Medicare Benefits Scheme in Australia, allowing eligible patients to access a number of rebates for their TMS sessions, and making TMS treatment more accessible for Australians. 📲 For regular updates on TMS, make sure to follow Modalis on Instagram and Facebook (with LinkedIn also available for medical practitioners). #tms #transcranialmagneticstimulation #repetitivetranscranialmagneticstimulation #rtms #brainstimulation #tmsaustralia #perthmedicalcommunity #TMSperth #depression #midland

It's #InternationalClinicalTrialsDay! Today, we would like to take the time to thank all of the doctors, nurses and patients who have taken part in our clinical trials👏 Clinical trials are integral to ensuring our SonoCloud system is safe and effective, so we can improve the treatment of brain diseases, such as #Alzheimers and #Glioblastoma Learn more about our clinical research here👇 https://lnkd.in/eZEveape #clinicaltrials #medtech

When as a clinician should augmentation strategies be used with patients? To see the full in-depth video with Dr. David Bloom and to learn more about augmentation strategies head to the Psych Scene Hub: https://lnkd.in/dG44PEnw For accredited learning on psychopharmacology head to The Academy: https://lnkd.in/gm_Ui2Jf #clinicians #augmentationstrategies #psychopharmacology

Save the Date: February 24th, 2024, the 6th International Lymphedema Symposium will be held under the scientific lead of Dr. med. Antonio Mander in Rome in the Italian language. We have planned a knowledge exchange on lymphological issues. As part of our Symposium we will focus on lymphedema, lipedema, multifactorial edemas, facial edemas and the therapeutic education. Our aim is to build bridges on several different levels: between scientific evidence and experience and between health care providers from different disciplines. The programme is targeted towards MDs, therapists, specialised nurses and compression specialists working in the field of the chronic condition lip- and lymphedema. We will discuss the best practice and cases. This platform should openly exchange ideas, update standards and gain insights into the latest scientific and therapeutic findings as well as build up personal connections that might be helpful to the future work – with the focus on the optimal treatment for our patients. Register now for attending in person! https://ow.ly/PFnr50PTlVp #symposium #romesymposium #lymph #lymphoedema #internationalsymposium #juzo #juzosymposium #lymphologicalissue #lymphodema #lipedema #multifacotaledema #therapeuticeducation #healthcare #compression #chroniccondition #medicine #bestpractice

Clear and empathetic #communication can make a big difference when it comes to #PatientOutcomes. In the video below, we share insights from 15 thought leaders in #neurogastroenterology on how providers can educate their patients with #DGBI effectively. We cover some of the most common clinical issues that should be addressed as well as how you discuss them in a way that isn't overwhelming. Check out the quick video below: #Healthcare #PX

🧠 New Study on Neurodevelopment in Hemophilia Patients! A recent study offers updated data on neurodevelopment in young hemophilia patients, highlighting advancements in care. The findings reveal that children with hemophilia are performing within or above age expectations in various cognitive areas, thanks to modern treatments. Learn more about these promising results and their impact on patient care: https://lnkd.in/gJ_bNWXd #NBDF

I'm thrilled to announce that I will be presenting our latest research at the ISPOR 2024 conference in Atlanta, GA, tomorrow, May 6, 2024! Join us for an in-depth look into our study on "Comparative Cost-Effectiveness Analysis of Interventions for Perinatal Methamphetamine Use Disorder: A Decision Modeling Method." 🔍 Study Overview: Our research utilizes a decision tree model to assess the direct medical costs and clinical outcomes for pregnant individuals diagnosed with Methamphetamine Use Disorder (MUD). We compared the effectiveness of Transcranial Magnetic Stimulation (TMS) against Naltrexone/Bupropion and no intervention, providing critical insights for healthcare decision-makers. #ISPORAnnual #HealthEconomics #PublicHealth #Research #PerinatalCare #MethamphetamineUseDisorder #TMS #HealthcareInnovation

🧠 New Study on Neurodevelopment in Hemophilia Patients! A recent study offers updated data on neurodevelopment in young hemophilia patients, highlighting advancements in care. The findings reveal that children with hemophilia are performing within or above age expectations in various cognitive areas, thanks to modern treatments. Learn more about these promising results and their impact on patient care: https://lnkd.in/gqij-iP4 #NBDF

This study shows that during the Early Intensive Neurorehabilitation program, a large percentage of people with PDOC regain at least a minimal conscious state or even consciousness. These outcomes and the frequent medical complications in this group suggest that intensive specialized care should be offered to all people with PDOC. The findings of this study may improve the medical care/management of people with PDOC and might help health professionals to inform the families of people with PDOC about the short-term prognosis of PDOC. Future research into long-term outcomes, quality of life and cost-effectiveness is necessary for further improvement of care/rehabilitation following PDOC and is on the way, Danielle Driessen Cecile U. Willemijn van Erp Majanka Heijenbrok-Kal

#Hi_Sonographer Analyzing clinical history is vital. This practice will aid in clinical practice. By correlating clinical findings with sonographic findings, the sonographer can directly impact the patient’s outcome by providing the most targeted examination possible. 🤩I will provides a review of common clinical indications for a pelvic sonogram and a list of differential gynecologic disorders. Keep following my posts😵💫😵💫